Skip to main navigation Skip to search Skip to main content

A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents

  • Maria Fasshauer
  • , Gesine Schuermann
  • , Norbert Gebert
  • , Horst von Bernuth
  • , Monika Bullinger
  • , Sigune Goldacker
  • , Renate Krueger
  • , Petra Manzey
  • , Stefanie Messner
  • , Ellen D. Renner
  • , Henrike Ritterbusch
  • , Uwe Schauer
  • , Ilka Schulze
  • , Volker Umlauf
  • , Steffi Widmann
  • , Ulrich Baumann
  • Children's Hospital
  • Hannover Medical School
  • Private Psychotherapeutische Praxis
  • Charité – Universitätsmedizin Berlin
  • Charite Universitätsmedizin Berlin
  • University Medical Center Hamburg-Eppendorf
  • University of Freiburg
  • Ludwig-Maximilians-Universität München
  • University Hospital Augsburg
  • Huntington-Zentrum (NRW) Bochum im St. Josef Hospital
  • KiJuMed-Gemeinschaftspraxis für Kinder- und Jugendmedizin sowie Kinder- und Jugendpsychotherapie
  • University Children's Hospital of Bern

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Aim: To assess a patient empowerment program (PEP) for children/adolescents with primary immunodeficiency (PID) on IgG replacement therapy regarding quality of life (QoL) in patients and proxy. Patients & methods: Health-related QoL was assessed using KIDSCREEN-27 and DISABKIDS-37 before and 6 months after PID-PEP kids in 19 children/adolescents and their parents. Results: The following three dimensions of the KIDSCREEN-27 significantly increased in children/adolescents after PID-PEP kids as compared with baseline: Psychological Well-Being, Parents & Autonomy and School Environment. Total DISABKIDS-37 index, as well as 5 of the 6 DISABKIDS-37 dimensions, significantly increased, in other words, Independence, Emotion, Social Inclusion, Social Exclusion and Physical. Evaluation of proxy instruments showed comparable results. Conclusion: PID-PEP kids significantly improved QoL in patients with PID.

Original languageEnglish
Pages (from-to)813-819
Number of pages7
JournalImmunotherapy
Volume16
Issue number12
DOIs
StatePublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Keywords

  • DISABKIDS-37
  • IgG replacement therapy
  • KIDSCREEN-27
  • education program
  • inborn errors of immunity
  • patient empowerment program
  • primary immunodeficiency
  • quality of life

Fingerprint

Dive into the research topics of 'A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents'. Together they form a unique fingerprint.

Cite this